Sarepta Therapeutics, Inc.
DE ˙ DB ˙ US8036071004
13,84 € ↓ -0,08 (-0,57%)
2026-06-04
DEL PRIS
SecurityDE:AB3A / Sarepta Therapeutics, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership40,141 shares
Latest Disclosed Value $ 873,330
Captrust Financial Advisors reports 17.66% decrease in ownership of AB3A / Sarepta Therapeutics, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 40,141 shares of Sarepta Therapeutics, Inc. (DE:AB3A) valued at $721,534 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 48,752 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -17.66% during the quarter. The current value of the position is $555,551 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 40,141 -8,611 -17.66 873 -16.78 0.0015
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 48,752 35,517 268.36 1,049 311.37 0.0020
2025-11-19 2025-09-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 13,235 13,235 255 0.0005
2025-05-15 2025-03-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 0 -4,468 -100.00 0 -100.00
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 4,468 597 15.42 543 12.42 0.0016
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 3,871 511 15.21 483 -8.87 0.0014
2024-08-15 2024-06-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 3,360 938 38.73 531 69.33 0.0017
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 2,422 -2,448 -50.27 314 -33.26 0.0012
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 4,870 -793 -14.00 470 -31.63 0.0016
2023-11-15 2023-09-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 5,663 -235 -3.98 686 1.63 0.0026
2023-08-15 2023-06-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 5,898 -826 -12.28 675 -27.11 0.0027
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 6,724 783 13.18 927 20.42 0.0041
2023-02-15 2022-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 5,941 2,153 56.84 770 83.53 0.0039
2022-11-16 2022-09-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 3,788 317 9.13 419 61.15 0.0024
2022-08-23 2022-06-30 13F/A-1 SAREPTA THERAPEUTICS INC COM Common Stock 803607100 3,471 44 1.28 260 -2.99 0.0017
2022-08-16 2022-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 3,534 107 265 0.0019
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 3,427 77 2.30 268 -11.26 0.0017
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 3,350 -2,627 -43.95 302 -45.39 0.0021
2021-11-16 2021-09-30 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 5,977 -665 -10.01 553 7.17 0.0046
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 6,642 -101 -1.50 516 2.58 0.0048
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 6,743 -142 -2.06 503 -57.16 0.0054
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 6,885 -70 -1.01 1,174 19.31 0.0156
2020-11-17 2020-09-30 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 6,955 -215 -3.00 984 -17.17 0.0163
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 7,170 -4,145 -36.63 1,188 12.93 0.0196
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS INC COM Common Stock 803607100 11,315 -765 -6.33 1,052 -32.52 0.0232
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 12,080 12,080 1,559 0.0246
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.